These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16080276)

  • 1. Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate.
    Nielsen P; Kongi R; Buggisch P; Fischer R
    Arzneimittelforschung; 2005; 55(7):376-81. PubMed ID: 16080276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients.
    Mimura EC; Breganó JW; Dichi JB; Gregório EP; Dichi I
    Nutrition; 2008; 24(7-8):663-8. PubMed ID: 18499399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of an iron retard preparation in patients with iron deficiency anemia].
    Nielsen P; Kongi R; Fischer R
    MMW Fortschr Med; 2016 Dec; 158(Suppl 6):17-23. PubMed ID: 27933573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative measurement of 59Fe-absorption. Comparison between iron labelled Parkevit-Fe and an iron-mono-preparation using a wholebody counter (author's transl)].
    Bräuer H
    MMW Munch Med Wochenschr; 1981 Jan; 123(5):181-3. PubMed ID: 6780894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia.
    Adsul BB; Desai A; Gawde A; Baliga V
    J Indian Med Assoc; 2005 Jun; 103(6):338-42. PubMed ID: 16225161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in distance runners. A reinvestigation using Fe-labelling and non-invasive liver iron quantification.
    Nachtigall D; Nielsen P; Fischer R; Engelhardt R; Gabbe EE
    Int J Sports Med; 1996 Oct; 17(7):473-9. PubMed ID: 8912060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food interaction of oral uptake of iron / a clinical trial using 59Fe.
    Lundqvist H; Sjöberg F
    Arzneimittelforschung; 2007; 57(6A):401-16. PubMed ID: 17691590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron absorption in patients with chronic uraemia. A comparative study using whole body counting and red cell incorporation of radioiron.
    Milman N
    Scand J Haematol; 1982 Jul; 29(1):5-17. PubMed ID: 6812212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of daily and weekly iron supplementation for the control of iron deficiency anaemia in infants in rural Vietnam].
    Nguyen XN; Berger J; Dao TQ; Nguyen CK; Traissac P; Ha HK
    Sante; 2002; 12(1):31-7. PubMed ID: 11943636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the management of iron deficiency anaemia.
    Goddard AF; James MW; McIntyre AS; Scott BB;
    Gut; 2011 Oct; 60(10):1309-16. PubMed ID: 21561874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights about iron bioavailability inhibition by zinc.
    Olivares M; Pizarro F; Ruz M
    Nutrition; 2007 Apr; 23(4):292-5. PubMed ID: 17350802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate.
    Pineda O; Ashmead HD
    Nutrition; 2001 May; 17(5):381-4. PubMed ID: 11377130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability of iron in oral iron preparations. Principles of duration and dosage (author's transl)].
    Heinrich HC; Gabbe EE
    MMW Munch Med Wochenschr; 1979 Aug; 121(35):1104-8. PubMed ID: 114773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of postabsorptive serum iron increase and erythrocyte-59Fe-incorporation with the whole body retention of absorbed 59Fe.
    Heinrich HC; Fischer R
    Klin Wochenschr; 1982 Dec; 60(24):1493-6. PubMed ID: 6820097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.